HUGroup Holdings (JP:4544)
:4544
Want to see JP:4544 full AI Analyst Report?
4544 Stock Chart & Stats
¥3729.00
¥5.00(0.19%)
At close: 4:00 PM EST
¥3729.00
¥5.00(0.19%)
Day’s Range― - ―
52-Week Range¥2,912.00 - ¥4,093.00
Previous CloseN/A
Volume178.60K
Average Volume (3M)243.85K
Market Cap
¥184.33B
Enterprise Value¥205.33B
Total Cash (Recent Filing)¥48.10B
Total Debt (Recent Filing)¥74.33B
Price to Earnings (P/E)26.3
Beta0.37
Next Earnings
Aug 11, 2026EPS Estimate
23.44Next Dividend Ex-DateN/A
Dividend Yield3.72%
Share Statistics
EPS (TTM)123.02
Shares Outstanding57,492,320
10 Day Avg. Volume223,460
30 Day Avg. Volume243,853
Financial Highlights & Ratios
PEG Ratio0.17
Price to Book (P/B)1.30
Price to Sales (P/S)0.72
P/FCF Ratio9.33
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)121.16
Revenue Forecast (FY)¥259.71B
Bulls Say, Bears Say
Bulls Say
Consistent Cash GenerationHUGroup has repeatedly generated positive operating and free cash flow, including through a loss year, and delivered ~¥19.2B FCF in FY2026. Durable cash generation supports reinvestment, debt reduction, and dividend capacity, providing financial flexibility over the next 2–6 months.
Manageable LeverageLeverage is moderate with debt-to-equity roughly 0.5–0.7 and falling total debt in FY2026. A solid equity base and declining indebtedness reduce refinancing risk and support capital allocation choices, strengthening balance-sheet resilience against cyclical pressures.
Stable Fee-for-service ModelHUGroup’s core fee-for-service diagnostics and specimen logistics model creates steady revenue tied to healthcare utilization. This structural demand from hospitals and clinics provides predictable volume drivers and durable service revenues less prone to short-term market swings.
Bears Say
Volatile ProfitabilityProfitability has been inconsistent: strong margins in FY2022–FY2023 gave way to a FY2024 loss and only modest recovery later. Persistent margin volatility undermines earnings predictability and could constrain reinvestment or dividend stability if structural pressures persist.
Significant Revenue DeclineA sharp FY2026 revenue drop of about 13.9% signals demand or mix headwinds beyond short-term noise. Sustained or recurring top-line weakness would pressure margins and cash flow, reducing the company's ability to fund growth initiatives or further deleveraging.
Free Cash Flow SensitivityAlthough FCF remains positive, recent swings and a sharp FY2026 drop indicate sensitivity to working capital, profitability swings, and investment timing. This volatility can complicate planning and raises execution risk for sustained capital return or strategic spending.
HUGroup Holdings News
4544 FAQ
What was HUGroup Holdings’s price range in the past 12 months?
HUGroup Holdings lowest stock price was ¥2912.00 and its highest was ¥4093.00 in the past 12 months.
What is HUGroup Holdings’s market cap?
HUGroup Holdings’s market cap is ¥184.33B.
When is HUGroup Holdings’s upcoming earnings report date?
HUGroup Holdings’s upcoming earnings report date is Aug 11, 2026 which is in 86 days.
How were HUGroup Holdings’s earnings last quarter?
HUGroup Holdings released its earnings results on May 14, 2026. The company reported ¥22.09 earnings per share for the quarter, beating the consensus estimate of ¥21.284 by ¥0.806.
Is HUGroup Holdings overvalued?
According to Wall Street analysts HUGroup Holdings’s price is currently Overvalued.
Does HUGroup Holdings pay dividends?
HUGroup Holdings pays a Semiannually dividend of ¥63 which represents an annual dividend yield of 3.72%. See more information on HUGroup Holdings dividends here
What is HUGroup Holdings’s EPS estimate?
HUGroup Holdings’s EPS estimate is 23.44.
How many shares outstanding does HUGroup Holdings have?
HUGroup Holdings has 57,492,320 shares outstanding.
What happened to HUGroup Holdings’s price movement after its last earnings report?
HUGroup Holdings reported an EPS of ¥22.09 in its last earnings report, beating expectations of ¥21.284. Following the earnings report the stock price went up 2.967%.
Which hedge fund is a major shareholder of HUGroup Holdings?
Currently, no hedge funds are holding shares in JP:4544
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
HUGroup Holdings
H.U. Group Holdings, Inc., through its subsidiaries, provides laboratory testing products and services in Japan. The company offers lab testing and its related services to medical institutions; self-medication services; food, environment, and cosmetic testing services; and testing services through corporate health insurance associations. It also researches, develops, manufactures, and sells in vitro diagnostic devices, which includes the LUMIPULSE, an automatic chemiluminescent enzyme immunoassay system that offers reagents for infectious disease, cancer, and lifestyle disease to medical institutions and testing centers; and ESPRINE, a rapid diagnostics kit series for influenza, hepatitis B, and the novel coronavirus, as well as supplies ingredients for test drugs. In addition, the company provides support services related to hospital administration work, including aid for surgical procedures and endoscope room work, inspection and maintenance services for medical equipment, and in-hospital logistics management and transportation services; and rents and sells nursing-care equipment and supplies. Further, it offers home-visit nursing care services. The company was formerly known as Miraca Holdings Inc. and changed its name to H.U. Group Holdings, Inc. in July 2020. H.U. Group Holdings, Inc. was incorporated in 1950 and is headquartered in Tokyo, Japan.
Technical Analysis
Ship Healthcare Holdings
―
Medley
―
Create SD Holdings Co., Ltd.
―
Solasto Corp.
―
Genky DrugStores Co., Ltd.
―
Options Prices
Currently, No data available
---